Assessing MC-I availability by [18F]BCPP-EF PET may constitute a valuable tool for evaluating the pathophysiology of AD from the perspective of mitochondrial hypothesis, which can open numerous therapeutic avenues. The gene discussed is MCIDAS; the disease is Alzheimer disease.